Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Leverger

Showing results (141-150 of 199) with videos related to

Pageof 20
Sort By:
Journal of Pediatric Hematology/Oncology|June 10, 2003
Economic evaluation of recombinant human granulocyte colony-stimulating factor in very high-risk childhood acute lymphoblastic leukemiaJean Delorme, Stéphanie Badin, Anne-Gaelle G Le Corroller, et al.
International Journal of Epidemiology|March 19, 2014
Cohort Profile: the French childhood cancer survivor study for leukaemia (LEA Cohort)Julie Berbis, Gérard Michel, André Baruchel, et al.
Blood|March 17, 2016
Comprehensive mutational profiling of core binding factor acute myeloid leukemiaNicolas Duployez, Alice Marceau-Renaut, Nicolas Boissel, et al.
Blood|March 22, 2003
Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML IntergroupJacques Delaunay, Norbert Vey, Thierry Leblanc, et al.
Haematologica|July 9, 2013
The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrestRaouf Ben Abdelali, Vahid Asnafi, Arnaud Petit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trialsNicolas Boissel, Marie-Françoise Auclerc, Véronique Lhéritier, et al.
Pediatric Blood & Cancer|September 26, 2022
The French FRACTURE database: A way to improve knowledge on management of children with very rare tumorsCoralie Mallebranche, Yves Reguerre, Brice Fresneau, et al.
Blood|May 24, 2018
Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APLAnna Maria Testi, Andrea Pession, Daniela Diverio, et al.
British Journal of Haematology|August 18, 2018
Excellent outcomes in children and adolescents with CNS<sup>+</sup> Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1J Kimble Frazer, Kevin J Li, Paul J Galardy, et al.
Leukemia|June 25, 2026
Genomic landscape of acute myeloid leukemia in adolescents and young adultsLoïc Vasseur, Nicolas Duployez, Jérôme Lambert, et al.
Pageof 20

Showing results (141-150 of 199) with videos related to

Sort By:
Pageof 20
Journal of Pediatric Hematology/Oncology|June 10, 2003
Economic evaluation of recombinant human granulocyte colony-stimulating factor in very high-risk childhood acute lymphoblastic leukemiaJean Delorme, Stéphanie Badin, Anne-Gaelle G Le Corroller, et al.
International Journal of Epidemiology|March 19, 2014
Cohort Profile: the French childhood cancer survivor study for leukaemia (LEA Cohort)Julie Berbis, Gérard Michel, André Baruchel, et al.
Blood|March 17, 2016
Comprehensive mutational profiling of core binding factor acute myeloid leukemiaNicolas Duployez, Alice Marceau-Renaut, Nicolas Boissel, et al.
Blood|March 22, 2003
Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML IntergroupJacques Delaunay, Norbert Vey, Thierry Leblanc, et al.
Haematologica|July 9, 2013
The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrestRaouf Ben Abdelali, Vahid Asnafi, Arnaud Petit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2003
Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trialsNicolas Boissel, Marie-Françoise Auclerc, Véronique Lhéritier, et al.
Pediatric Blood & Cancer|September 26, 2022
The French FRACTURE database: A way to improve knowledge on management of children with very rare tumorsCoralie Mallebranche, Yves Reguerre, Brice Fresneau, et al.
Blood|May 24, 2018
Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APLAnna Maria Testi, Andrea Pession, Daniela Diverio, et al.
British Journal of Haematology|August 18, 2018
Excellent outcomes in children and adolescents with CNS<sup>+</sup> Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1J Kimble Frazer, Kevin J Li, Paul J Galardy, et al.
Leukemia|June 25, 2026
Genomic landscape of acute myeloid leukemia in adolescents and young adultsLoïc Vasseur, Nicolas Duployez, Jérôme Lambert, et al.
Pageof 20